HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Visvanathan Ramamurthy Selected Research

Morpholinos

6/2004Zebrafish rx3 and mab21l2 are required during eye morphogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Visvanathan Ramamurthy Research Topics

Disease

7Leber Congenital Amaurosis
04/2014 - 04/2004
5Blindness (Hysterical Blindness)
01/2020 - 10/2003
3Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2018 - 04/2014
2Cone-Rod Dystrophies
02/2015 - 04/2014
1Huntington Disease (Huntington's Disease)
12/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2020
1Agenesis of Cerebellar Vermis
01/2019
1Male Infertility (Male Sterility)
01/2019
1Inborn Genetic Diseases (Disease, Hereditary)
01/2019
1Vision Disorders (Hemeralopia)
01/2019
1Ciliopathies
01/2019
1Retinitis Pigmentosa 2
01/2016
1Cone Dystrophy
02/2014
1Retinal Degeneration
12/2011
1Microphthalmos
06/2004
1Retinal Dystrophies
04/2004
1Acquired Immunodeficiency Syndrome (AIDS)
10/2003

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
12/2020 - 10/2003
5aryl hydrocarbon receptor-interacting proteinIBA
04/2014 - 03/2010
2Retinaldehyde (Retinal)IBA
01/2019 - 04/2004
2Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
11/2009 - 09/2004
1polyglutamineIBA
12/2020
1Proteoglycans (Proteoglycan)IBA
01/2020
1Monomeric GTP-Binding ProteinsIBA
01/2019
1Biological ProductsIBA
01/2019
1GTPase-Activating Proteins (GTPase-Activating Protein)IBA
01/2016
1Proline (L-Proline)FDA Link
02/2015
1EnzymesIBA
02/2014
1HydrocarbonsIBA
09/2004
1MorpholinosIBA
06/2004
1Guanylate Cyclase (Guanylyl Cyclase)IBA
04/2004

Therapy/Procedure

1Therapeutics
12/2011